Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 1, 1998, Pages 54-63

  Strenn, Karin ^b   Matulla, Bettina ^b   Wolzt, Michael ^b   Findl, Oliver ^b   Bekes, Maria Csilla ^b   Lamsfuss, Ulla ^b   Graselli, Ursula ^b   Rainer, Georg ^b   Menapace, Rupert ^b   Eichler, Hans Georg ^b   Schmetterer, Leopold ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; NIFEDIPINE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EYE BLOOD FLOW; EYE FUNDUS; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTERFEROMETRY; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; OPTIC DISK; PRIORITY JOURNAL;

ADULT; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIN-1; EYE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; NIFEDIPINE; REGIONAL BLOOD FLOW; TIME FACTORS; TREATMENT OUTCOME;

EID: 13144260635     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90121-7     Document Type: Article

References (39)

1. Kitazawa Y, Shirai H, Go FJ. The effect of Ca2+ antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:408-12.
2. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993; 115:608-13.
3. Pillunat LE, Lang GK, Harris A. Ocular carbon dioxide reactivity and calcium channel blockers in normal pressure glaucoma. In: Drance SM, editor. Update of glaucoma, ocular blood flow and drug treatment. Amsterdam: Kugler Publications; 1995. p. 67-71.
4. Harino S, Riva CE, Petrig BL. Intravenous nicardipine in cats increases optic nerve head but not retinal blood flow. Invest Ophthalmol Vis Sci 1992;33:2885-90.
5. Rankin SJA, Walman BE, Buckley AR, Drance SM. Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am J Ophthalmol 1995;119:685-93.
6. Harris A, Sergott RC, Spaeth GL, Katz JL, Shoemaker JA, Martin BJ. Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol 1994;118:642-9.
7. Hamard P, Hamard H, Dufaux J, Quesnot S. Optic nerve head blood flow using a laser Doppler velocimeter and hemorheology in primary open angle glaucoma and normal pressure glaucoma. Br J Ophthalmol 1994;78:449-53.
8. Sugiyama T, Moriya S, Oku H, Azuma H. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995; 39:849-56.
9. Yoo K, Tschudi M, Lüscher TF. Endothelium-dependent regulation of vascular tone on the porcine ophthalmic artery. Invest Ophthalmol Vis Sci 1991; 32:1791-8.
10. Haefliger IO, Flammer J, Lüscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 1992; 33:2340-3.
11. Meyer P, Lang MG, Flammer J, Lüscher TF. Effects of calcium channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries. Exp Eye Res 1995;60:505-10.
12. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, Trimble ER. The effect of endothelin 1 on the retinal microvascular pericyte. Microvasc Res 1992; 43:241-54.
13. Brown SM, Jampol LM. New concepts of regulation of retinal vascular tone. Arch Ophthalmol 1996;114: 199-204.
14. Cioffi GA, Orgül S, Onda E, Bacon DR, Van Buskirk EM. An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr Eye Res 1995; 14:1147-53.
15. Orgül S, Cioffi GA, Bacon DR, Van Buskirk EM. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma 1996;5: 135-8.
16. Schmetterer L, Findl O, Strenn K, Jilma B, Graselli U, Eichler HG, et al. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr Eye Res 1997;16:687-92.
17. Nyborg NCB, Prieto D, Benedito S, Nielsen PJ. Endothelin-1 induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. Invest Ophthalmol Vis Sci 1991;32:27-31.
18. Schmetterer L, Lexer F, Unfried C, Sattmann H, Percher A. Topical measurement of fundus pulsations. Opt Eng 1995;34:711-6.
19. Schmetterer L, Wolzt M, Salomon A, Rheinberger A, Unfried C, Zanaschka G, et al. The effect of isoproterenol, phenylephrine and sodium nitroprusside on fundus pulsations in healthy volunteers. Br J Ophthalmol 1996;80:217-23.
20. Michelson G, Groh M, Langhans M, Schmauss B. Zweidimensionale Kartierung der retinalen und papillären MikroZirkulation mittels Scanning-Laser-Doppler-Flowmetrie. Klin Monatsbl Augenheilkd 1995;207:180-90.
21. Michelson G, Langhans MJ, Groh MJM. Clinical investigation of the combination of a scanning laser ophthalmoscope and laser Doppler flowmeter. Ger J Ophthalmol 1995;4:342-9.
22. Schmetterer L, Strenn K, Findl O, Breiteneder H, Graselli U, Agneter E, et al. The effect of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin Pharmacol Ther 1997;61:583-95.
23. Langham ME, Tomey K. A clinical procedure for the measurement of the ocular pulse-pressure relationship and the ophthalmic arterial pressure. Exp Eye Res 1978;27:17-25.
24. Langham ME, Farrell RA, O'Brien V, Silver DM, Schilder P. Blood flow in the human eye. Acta Ophthalmol 1989;67(suppl 191):9-13.
25. Flammer J, Guthauser U. Behandlung choroidaler Vasospasmen mit Kalziumantagonisten. Klin Monatsbl Augenheilkd 1987;190:199-200.
26. Harris A, Cantor B, Edwards JD. Long term hemodynamic and visual function changes in normal tension glaucoma treated with oral nifedipine. Ophthalmology 1995;102(suppl):90.
27. Schmidt KG, Mittag TW, Pavlovic S, Ressemer V. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol 1996;234:527-32.
28. Drance SM. Some factors in the production of low tension glaucoma. Br J Ophthalmol 1972;56:229-42.
29. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head ischaemic disorders. Am J Ophthalmol 1994;117:603-24.
30. Netland PA, Grosskreutz CL, Feke GT, Hart LJ. Color Doppler analysis of ocular circulation alter topical calcium channel blocker. Am J Ophthalmol 1995; 119:694-700.
31. Netland PA, Feke GT, Konno S, Goger DG, Fujio N. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma 1996;5:200-6.
32. Vierhapper H, Wagner O, Nowotny P, Waldhäusl W. Effect of endothelin-1 in man. Circulation 1990;81: 1415-8.
33. Kaiser IH, Flammer J, Wenk M, Lüscher T. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal responses to postural changes. Graefes Arch Clin Exp Ophthalmol 1995;233:481-8.
34. Andrawis NS, Gilligan J, Abernethy DR. Endothelin-I mediated vasoconstriction: specific blockade by verapamil. Clin Pharmacol Ther 1992;52: 583-9.
35. Bauer LA, Murray K, Horn JR, Opheim K, Olesen J. Influence of nifedipine therapy on indocyanine green and oral propanolol pharmacokinetics. Eur J Clin Pharmacol 1989;37:257-60.
36. Reiss WG, Bauer LA, Horn JR, Zierler BK, Easterling TR, Strandness DE. The effects of oral nifedipine on hepatic blood flow in humans. Clin Pharmacol Ther 1991;50:379-84.
37. Fletcher AE, Bulpitt CJ, Chase DM, Collins WC, Furberg CD, Goggin TK, et al. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension 1992;19:499-507.
38. Bayley S, Dobbs RJ, Robinson BF. Nifedipine in the treatment of hypertension: report of a double blind uncontrolled trial. Br J Clin Pharmacol 1982;14:509-12.
39. Palmer A, Fletcher A, Hamilton G, Muriss S, Bulgitt C. A comparison of verapamil and nifedipine on quality of life. Br J Clin Pharmacol 1990;30:365-70.